Our PET images and autoradiography results, combined with the known pattern of CD8+ T cell localization in oHSV-treated glioma tumors, suggest that the tumor uptake of [89Zr]-malDFO-169 cDb observed in M002-treated mice was mediated by CD8+ cells in response to oHSV immunotherapy. Here, CD8A is linked to central nervous system cancer.